Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial

BACKGROUND: Major Depressive Disorder (MDD) has been associated with brain-related changes. However, biomarkers have yet to be defined that could “accurately” identify antidepressant-responsive patterns and reduce the trial-and-error process in treatment selection. Cerebral blood perfusion, as measu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EClinicalMedicine
Main Authors: Cooper, Crystal M., Chin Fatt, Cherise R., Jha, Manish, Fonzo, Gregory A., Grannemann, Bruce D., Carmody, Thomas, Ali, Aasia, Aslan, Sina, Almeida, Jorge R.C., Deckersbach, Thilo, Fava, Maurizio, Kurian, Benji T., McGrath, Patrick J., McInnis, Melvin, Parsey, Ramin V., Weissman, Myrna, Phillips, Mary L., Lu, Hanzhang, Etkin, Amit, Trivedi, Madhukar H.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6543260/
https://ncbi.nlm.nih.gov/pubmed/31193824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2019.04.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados